IgG4-related orbital disease

Last revised by Yew Shiong Leong on 13 Dec 2022

IgG4-related orbital or ophthalmic disease is a manifestation of systemic IgG4-related disease that accounts for a substantial minority of what was previously considered idiopathic orbital inflammation (orbital pseudotumor).

Patients usually present with either painless periorbital/eyelid swelling or proptosis, with or without diplopia 1-3. Pain affects a small fraction 3.

Within the orbit, IgG4-related disease can involve one or multiple tissue compartments, including the lacrimal gland (dacryoadenitis), extraocular muscles (orbital myositis), orbital fat, sclera, and cranial nerve branches. The most common sites are the lacrimal gland and extraocular muscles, which are affected in the majority of patients with this diagnosis 1-3.

Orbital IgG4-related disease requires immunohistochemistry demonstrating at least 30 IgG4-positive plasma cells per high power field 4.

On CT and MRI, the primary imaging features are enlargement of the lacrimal gland and/or extraocular muscle(s) 3. Involvement is bilateral in a majority 1,3. The muscle most often affected and most prominently enlarged is the lateral rectus muscle 3. The anterior tendon is spared in the vast majority 3.

Supportive features present in a minority of cases include inflammation in the orbital fat, infraorbital nerve enlargement, and paranasal sinus disease 3.

The entity overlaps with other infiltrative disorders of the orbit.

  • thyroid-associated orbitopathy commonly causes tendon-sparing extraocular muscle enlargement, but it does not involve the lateral rectus until late in the disease and does not involve the infraorbital nerve 3,5

  • idiopathic orbital inflammation can also cause extraocular muscle enlargement, but it usually involves the anterior tendon, is more commonly unilateral, and more often affects the medial rectus than lateral rectus 3

  • orbital lymphoma

See these separate articles for a full differential:

ADVERTISEMENT: Supporters see fewer/no ads